| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cell and Molecular Biology (H.G., C.S., B.V.), Karolinska Institute, S-171 77 Stockholm, Sweden; Centers for Metabolism and Endocrinology and Nutrition and Toxicology (M.R., B.A.), Department of Medicine, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden; and Department of Human Genetics (D.F.), Mount Sinai School of Medicine, New York, New York 10029
Address all correspondence and requests for reprints to: Dr. Björn Vennström, Department of Cell and Molecular Biology, Karolinska Institute, Room D427 Doktorsringen 2D, Solna, Sweden S-171 77. E-mail: bjorn.vennstrom{at}cmb.ki.se.
T3 potently influences cholesterol metabolism through the nuclear thyroid hormone receptor ß (TRß), the most abundant TR isoform in rodent liver. Here, we have tested if TR
1, when expressed at increased levels from its normal locus, can replace TRß in regulation of cholesterol metabolism. By the use of TR
2-/-ß-/- animals that overexpress hepatic TR
1 6-fold, a near normalization of the total amount of T3 binding receptors was achieved. These mice are similar to TRß-/- and TR
1-/-ß-/- mice in that they fail to regulate cholesterol 7
-hydroxylase expression properly, and that their serum cholesterol levels are unaffected by T3. Thus, hepatic overexpression of TR
1 cannot substitute for absence of TRß, suggesting that the TRß gene has a unique role in T3 regulation of cholesterol metabolism in mice. However, examination of T3 regulation of hepatic target genes revealed that dependence on TRß is not general: T3 regulation of type I iodothyronine deiodinase and the low density lipoprotein receptor were partially rescued by TR
1 overexpression. These in vivo data show that TRß is necessary for the effects of T3 on cholesterol metabolism. That TR
1 only in some instances can substitute for TRß indicates that T3 regulation of physiological and molecular processes in the liver occurs in an isoform-specific fashion.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
M. Vujovic, K. Nordstrom, K. Gauthier, F. Flamant, T. J. Visser, B. Vennstrom, and J. Mittag Interference of a Mutant Thyroid Hormone Receptor {alpha}1 with Hepatic Glucose Metabolism Endocrinology, June 1, 2009; 150(6): 2940 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tancevski, A. Wehinger, E. Demetz, J. Hoefer, P. Eller, E. Huber, U. Stanzl, K. Duwensee, K. Auer, W. Schgoer, et al. The thyromimetic T-0681 protects from atherosclerosis J. Lipid Res., May 1, 2009; 50(5): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Araki, H. Ying, X. G. Zhu, M. C. Willingham, and S. Y. Cheng Distinct Dysregulation of Lipid Metabolism by Unliganded Thyroid Hormone Receptor Isoforms Mol. Endocrinol., March 1, 2009; 23(3): 308 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Berkenstam, J. Kristensen, K. Mellstrom, B. Carlsson, J. Malm, S. Rehnmark, N. Garg, C. M. Andersson, M. Rudling, F. Sjoberg, et al. From the Cover: The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans PNAS, January 15, 2008; 105(2): 663 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quignodon, S. Vincent, H. Winter, J. Samarut, and F. Flamant A Point Mutation in the Activation Function 2 Domain of Thyroid Hormone Receptor {alpha}1 Expressed after CRE-Mediated Recombination Partially Recapitulates Hypothyroidism Mol. Endocrinol., October 1, 2007; 21(10): 2350 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Flamant, K. Gauthier, and J. Samarut Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming Mol. Endocrinol., February 1, 2007; 21(2): 321 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Shin, M. Plateroti, J. Samarut, and T. F. Osborne Two uniquely arranged thyroid hormone response elements in the far upstream 5' flanking region confer direct thyroid hormone regulation to the murine cholesterol 7{alpha} hydroxylase gene Nucleic Acids Res., September 1, 2006; 34(14): 3853 - 3861. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fugier, J.-J. Tousaint, X. Prieur, M. Plateroti, J. Samarut, and P. Delerive The Lipoprotein Lipase Inhibitor ANGPTL3 Is Negatively Regulated by Thyroid Hormone J. Biol. Chem., April 28, 2006; 281(17): 11553 - 11559. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, R. N. Cohen, M. Yamada, K. R. Markan, T. Monden, T. Satoh, M. Mori, and F. E. Wondisford Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model J. Biol. Chem., January 6, 2006; 281(1): 295 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Shea, J. H. D. Bassett, S. Sriskantharajah, H. Ying, S.-y. Cheng, and G. R. Williams Contrasting Skeletal Phenotypes in Mice with an Identical Mutation Targeted to Thyroid Hormone Receptor {alpha}1 or {beta} Mol. Endocrinol., December 1, 2005; 19(12): 3045 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice PNAS, July 19, 2005; 102(29): 10297 - 10302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Hapon, S. M. Varas, G. A. Jahn, and M. S. Gimenez Effects of hypothyroidism on mammary and liver lipid metabolism in virgin and late-pregnant rats J. Lipid Res., June 1, 2005; 46(6): 1320 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Zavacki, H. Ying, M. A. Christoffolete, G. Aerts, E. So, J. W. Harney, S.-y. Cheng, P. R. Larsen, and A. C. Bianco Type 1 Iodothyronine Deiodinase Is a Sensitive Marker of Peripheral Thyroid Status in the Mouse Endocrinology, March 1, 2005; 146(3): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pircher, P. Chomez, F. Yu, B. Vennstrom, and L. Larsson Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbA{alpha} orphan receptor gene Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R482 - R490. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Mengeling, F. Pan, and M. L. Privalsky Novel Mode of Deoxyribonucleic Acid Recognition by Thyroid Hormone Receptors: Thyroid Hormone Receptor {beta}-Isoforms Can Bind as Trimers to Natural Response Elements Comprised of Reiterated Half-Sites Mol. Endocrinol., January 1, 2005; 19(1): 35 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-h. Shih, S.-L. Chen, C.-C. Yen, Y.-H. Huang, C.-d. Chen, Y.-S. Lee, and K.-h. Lin Thyroid Hormone Receptor-Dependent Transcriptional Regulation of Fibrinogen and Coagulation Proteins Endocrinology, June 1, 2004; 145(6): 2804 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Doulabi, M. P.-T. Schiphorst, A. Kalsbeek, E. Fliers, O. Bakker, and W. M. Wiersinga Diurnal Variation in Rat Liver Thyroid Hormone Receptor (TR)-{alpha} Messenger Ribonucleic Acid (mRNA) Is Dependent on the Biological Clock in the Suprachiasmatic Nucleus, whereas Diurnal Variation of TR{beta}1 mRNA Is Modified by Food Intake Endocrinology, March 1, 2004; 145(3): 1284 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. B. Drover and L. B. Agellon Regulation of the Human Cholesterol 7{alpha}-Hydroxylase Gene (CYP7A1) by Thyroid Hormone in Transgenic Mice Endocrinology, February 1, 2004; 145(2): 574 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. van Beeren, W. M. C. Jong, E. Kaptein, T. J. Visser, O. Bakker, and W. M. Wiersinga Dronerarone Acts as a Selective Inhibitor of 3,5,3'-Triiodothyronine Binding to Thyroid Hormone Receptor-{alpha}1: In Vitro and in Vivo Evidence Endocrinology, February 1, 2003; 144(2): 552 - 558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |